RIA
REGN icon

Regal Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Regal Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-43
Closed -$12K – 933
2013
Q4 		$12K Hold
43
– – 0.01% 554
2013
Q3 		$13K Buy
+43
New +$11.3K 0.01% 557

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Regal Investment Advisors's REGN Position: Q1 2014 in Review

Regal Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q1 2014, closing a stake of 43 shares — an estimated $12K sold.

Regal Investment Advisors first reported a position in REGN in Q3 2013 and held it in 2 quarters. The position peaked at $13K in Q3 2013. 453 funds tracked by Wall St. Rank hold REGN as of Q1 2014.

  • Regal Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Regal Investment Advisors sold 43 Regeneron Pharmaceuticals shares in Q1 2014, an estimated $12K.
  • Regal Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 2 quarters.
  • Regal Investment Advisors's Regeneron Pharmaceuticals position peaked at $13K in Q3 2013.
  • 453 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2014.

Based on Regal Investment Advisors's 13F filing for Q1 2014, filed 18 Apr 2014.